Developing a self-regulated system that can accurately measure a patient’s blood-glucose levels, determine the perfect insulin dose for that particular patient at that exact time, and then deliver the insulin through a connected, wearable insulin-pump has been a goal for type-1 diabetes researchers for some time. According to NBC News, this trio of devices (blood-glucose meter, computation device, and insulin pump), also known as the “artificial pancreas,” could be available for patients as soon as next year.
Dublin-based Medtronic is expected to release their technology in 2017, and the University of Virginia Center for Diabetes Technology will soon begin the final stages of clinical trials on the version they have been developing with TypeZero Technologies. Programs at Cambridge University and Boston University, led by Professor Edward Damiano, are also focused on creating an artificial pancreas, but with the added feature of measuring glucagon in the blood.
Photo Attribution: Frederucj Florin | AFP | Getty Images